cbdMD Announces Spring 2021 New Products Launch
Line Extension of Award Winning, Best Selling
cbdMD Gummies To Include:
cbdMD Sleep Gummies, cbdMD Calming Gummies and
cbdMD Apple Cider Vinegar Gummies
cbdMD Also Announced Launch of Its First Ever
cbdMD Drink Mixes To Include:
cbdMD Energy Drink Mix, cbdMD Recovery Drink
Mix and More
cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one
of the leading and most highly trusted and recognized cannabidiol
(CBD) brands, announced today that its Spring 2021 product launch
will include a line extension of the cbdMD award-winning and
best-selling Gummies, as well as the first ever, and highly
anticipated, cbdMD Drink Mixes.
This press release features multimedia. View
the full release here:
cbdMD’s new Gummies will include: cbdMD
Sleep Gummies, cbdMD Calming Gummies and cbdMD Apple Cider Vinegar
Gummies. (Photo: Business Wire)
“cbdMD has always been at the forefront of product innovation in
the growing CBD industry. Our customers know that when they buy a
cbdMD branded product, it is made with the highest possible
industry standards and with our patented pending formulated blends.
We are excited to get these new products out to our customers and
onto the shelves of our retail partners,” said Martin A.
Sumichrast, Chairman and co-CEO of cbdMD, Inc.
cbdMD’s new Gummies will include: cbdMD Sleep Gummies, cbdMD
Calming Gummies and cbdMD Apple Cider Vinegar Gummies. Each bottle
will have 30 Gummies and be available in 10MG, 25MG and 50MG
strengths (per gummy) and will be priced from $29.95 to $89.95.
cbdMD Drink Mix
cbdMD Drink Mixes will have 25MG of CBD and will be available in
four basic flavors (Fruit Punch, Lemonade, Peach and Strawberry),
as well as two Energy Drink flavors (Blackberry and Blood Orange)
and two Recovery Drink Flavors (Lemon Lime and Grape). Each packet
will be available in 5 and 10 packs and will be priced $29.95 to
$69.95 per pack.
About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most highly trusted and
most recognized cannabidiol (CBD) brands with a comprehensive line
of U.S. produced, THC-free1 CBD products. Our cbdMD brand currently
includes over 130 SKUs of high-grade, premium CBD products
including CBD tinctures, CBD gummies, CBD topicals, CBD capsules,
CBD bath bombs, CBD bath salts, CBD sleep aids and CBD drink mixes.
Our Paw CBD brand of pet products includes over 45 SKUs of
veterinarian-formulated products including tinctures, chews,
topicals products in varying strengths, and our CBD Botanicals
brand of beauty and skincare products features 15 SKUs, including
facial oil and serum, toners, moisturizers, clear skin, facial
masks, exfoliants and body care. Please visit www.cbdMD.com, follow
cbdMD on Instagram and Facebook, or visit one of the 6,000 retail
outlets that carry cbdMD products. To learn more about cbdMD and
their comprehensive line of U.S. grown, THC-free CBD oil
products, please visit www.cbdmd.com.
This press release contains certain forward-looking statements
that are based upon current expectations and involve certain risks
and uncertainties within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Such forward-looking statements can
be identified by the use of words such as ''should,'' ''may,''
''intends,'' ''anticipates,'' ''believes,'' ''estimates,''
''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and
''proposes.'' These forward-looking statements are not guarantees
of future performance and are subject to risks, uncertainties, and
other factors, some of which are beyond our control and difficult
to predict. You are urged to carefully review and consider any
cautionary statements and other disclosures, including the
statements made under the heading "Risk Factors" in cbdMD, Inc.'s
Annual Report on Form 10-K for the fiscal year ended September 30,
2020 as filed with the Securities and Exchange Commission (the
"SEC") on December 22, 2020 and our other filings with the SEC. All
forward-looking statements involve significant risks and
uncertainties that could cause actual results to differ materially
from those in the forward-looking statements, many of which are
generally outside the control of cbdMD, Inc. and are difficult to
predict. cbdMD, Inc. does not undertake any duty to update any
forward-looking statements except as may be required by law. The
information which appears on our websites and our social media
platforms, including, but not limited to, Instagram and Facebook,
is not part of this press release.
1 THC-free is defined as below the level of detection using
validated scientific analytical tools.
version on businesswire.com: https://www.businesswire.com/news/home/20210420005706/en/
PR: 5W Public Relations cbdMD@5wpr.com (212) 999-5585
Investors: cbdMD, Inc., John Weston, Director of Investor
Relations John.Weston@cbdMD.com (704) 249-9515